Erratum to "BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines" [Antivir. Res. 80 (2020) 104814]

Antiviral Res. 2022 Apr:200:105293. doi: 10.1016/j.antiviral.2022.105293. Epub 2022 Mar 22.

Authors

Aqsa Iqbal¹, Rahul Suryawanshi¹, Tejabhiram Yadavalli¹, Ipsita Volety¹, Deepak Shukla²

Affiliations

¹ Department of Ophthalmology and Visual Sciences, University of Illinois Medical Center, Chicago, IL, 60612, USA.
² Department of Ophthalmology and Visual Sciences, University of Illinois Medical Center, Chicago, IL, 60612, USA; Department of Bioengineering, University of Illinois, Chicago, IL, 60607, USA. Electronic address: dshukla@uic.edu.

No abstract available

Publication types

Published Erratum

Grants and funding

R01 AI139768/AI/NIAID NIH HHS/United States